Literature DB >> 23273776

Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients.

Frank N Angelo1, Michael G McDonell, Michael R Lewin, Debra Srebnik, Jessica Lowe, John Roll, Richard Ries.   

Abstract

BACKGROUND: Severe mental illness is often exclusionary criteria for studies examining factors that influence addiction treatment outcome. Therefore, little is known about predictors of treatment response of individuals receiving psychosocial treatments for addictions who suffer from co-occurring severe mental illness.
METHODS: The impact of demographic, substance abuse severity, psychiatric severity, and service utilization variables on in-treatment performance (i.e., longest duration of abstinence) in a 12-week contingency management (CM) intervention for stimulant abuse in 96 severely mentally ill adults was investigated. A 4-step linear regression was used to identify independent predictors of in-treatment abstinence.
RESULTS: This model accounted for 37.4% of variance in the longest duration of abstinence outcome. Lower levels of stimulant use (i.e., stimulant-negative urine test) and psychiatric severity (i.e., lower levels of psychiatric distress), as well as higher rates of outpatient treatment utilization at study entry were independently associated with longer duration of drug abstinence.
CONCLUSION: These data suggest that individuals with low levels of stimulant use and psychiatric severity, as well as those actively engaged in services are most likely to succeed in a typical CM intervention. For others, modifications to CM interventions, such as increasing the value of reinforcement or adding CM to evidence based psychiatric interventions may improve treatment outcomes.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23273776      PMCID: PMC3616149          DOI: 10.1016/j.drugalcdep.2012.11.017

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  32 in total

1.  Treating substance abuse in schizophrenia. An initial report.

Authors:  M E Bennett; A S Bellack; J S Gearon
Journal:  J Subst Abuse Treat       Date:  2001-03

Review 2.  Managing comorbid schizophrenia and substance abuse.

Authors:  R E Drake; K T Mueser
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

3.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.

Authors:  D A Regier; M E Farmer; D S Rae; B Z Locke; S J Keith; L L Judd; F K Goodwin
Journal:  JAMA       Date:  1990-11-21       Impact factor: 56.272

4.  Methadone plus contingency management or performance feedback reduces cocaine and opiate use in people with drug addiction.

Authors:  Nancy M Petry
Journal:  Evid Based Ment Health       Date:  2005-11

5.  Co-occurring disorders among mentally ill jail detainees. Implications for public policy.

Authors:  K M Abram; L A Teplin
Journal:  Am Psychol       Date:  1991-10

6.  Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial.

Authors:  Amanda Baker; Sandra Bucci; Terry J Lewin; Frances Kay-Lambkin; Paul M Constable; Vaughan J Carr
Journal:  Br J Psychiatry       Date:  2006-05       Impact factor: 9.319

7.  Acceptability of contingency management among clinicians and clients within a co-occurring mental health and substance use treatment program.

Authors:  Debra Srebnik; Andrea Sugar; Patrick Coblentz; Michael G McDonell; Frank Angelo; Jessica M Lowe; Richard K Ries; John Roll
Journal:  Am J Addict       Date:  2013 Sep-Oct

8.  A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

Authors:  Alan S Bellack; Melanie E Bennett; Jean S Gearon; Clayton H Brown; Ye Yang
Journal:  Arch Gen Psychiatry       Date:  2006-04

9.  The role of psychiatric disorders in predicting drug dependence treatment outcomes.

Authors:  Wilson M Compton; Linda B Cottler; Jacqueline L Jacobs; Arbi Ben-Abdallah; Edward L Spitznagel
Journal:  Am J Psychiatry       Date:  2003-05       Impact factor: 18.112

Review 10.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

View more
  5 in total

1.  Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness.

Authors:  Michael Gerard McDonell; Emily Leickly; Sterling McPherson; Jordan Skalisky; Katherine Hirchak; Oladunni Oluwoye; Debra Srebnik; John Michael Roll; Richard Kirkland Ries
Journal:  Am J Addict       Date:  2017-08-18

2.  Using a randomized controlled trial to test whether modifications to contingency management improve outcomes for heavy drinkers with serious mental illness.

Authors:  Oladunni Oluwoye; Jordan Skalisky; Ekaterina Burduli; Naomi S Chaytor; Sterling McPherson; Sean M Murphy; Jalene Herron; Katherine Hirchak; Mason Burley; Richard K Ries; John M Roll; Michael G McDonell
Journal:  Contemp Clin Trials       Date:  2018-04-20       Impact factor: 2.226

3.  Serious Mental Illness in Heavy Drinkers Is Associated with Poor Treatment Outcomes in Outpatients with Co-occurring Disorders.

Authors:  Oladunni Oluwoye; Emily Leickly; Jordan Skalisky; Sterling McPherson; Katherine Hirchak; Debra Srebnik; John M Roll; Richard K Ries; Michael G McDonell
Journal:  Int J Ment Health Addict       Date:  2017-10-31       Impact factor: 3.836

4.  Psychosocial interventions for people with both severe mental illness and substance misuse.

Authors:  Glenn E Hunt; Nandi Siegfried; Kirsten Morley; Carrie Brooke-Sumner; Michelle Cleary
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12

Review 5.  A review of contingency management for the treatment of substance-use disorders: adaptation for underserved populations, use of experimental technologies, and personalized optimization strategies.

Authors:  Sterling M McPherson; Ekaterina Burduli; Crystal Lederhos Smith; Jalene Herron; Oladunni Oluwoye; Katherine Hirchak; Michael F Orr; Michael G McDonell; John M Roll
Journal:  Subst Abuse Rehabil       Date:  2018-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.